Search Results 1781-1790 of 19992 for Receptor
Previous use of systemic therapy targeting colony stimulating factor 1 (CSF1) or CSFR1 receptor (CSF1R); previous therapy with imatinib and nilotinib is allowed ...
Exploring the Role of B-cell Activating Factor Receptor (BAFFR)-based Chimeric Antigen Receptor T-cell (CAR T) in BAFFR-expressing B-cell Hematologic ...
The disease is difficult to treat because the tumors are missing the estrogen, progesterone and HER-2 receptors that are the target of the most common and ...
... receptor positive uterine carcinosarcoma: A case report. Gynecol Oncol Rep. 2021 Nov; 38:100877 Epub 2021 Oct 04. View PubMed; Katebi Kashi P, Hopkins MR ...
TPO plays a key role in getting the thyroid to make hormones that are crucial to health. But in some people who have thyroid disease, the immune system ...
Researchers seek to improve success of chimeric antigen receptor-T cell therapy in non- · Research · Research · Science Saturday: What you should know about ...
ROCHESTER, Minn. — Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T-cell therapy, ...
T-cell receptor diversity may be key to treatment of follicular lymphoma, Mayo study. Cancer. T-cell receptor diversity may be key to treatment of ...
Chimeric antigen receptor-T cell therapy (CAR-T cell therapy) could provide a revolutionary approach to organ transplantation for patients who are hard to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.